Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort
Olutasidenib治疗IDH1突变型急性髓系白血病:II期关键队列的五年最终结果
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-025-01751-w
Cortes, Jorge; Curti, Antonio; Fenaux, Pierre; Jonas, Brian A; Krauter, Jürgen; Montesinos, Pau; Récher, Christian; Taussig, David C; Wang, Eunice S; Watts, Justin; Wei, Andrew; Yee, Karen Wl; Tian, Hua; Sheppard, Aaron; Marzac, Christophe; de Botton, Stephane